Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (11-20 of 422) with videos related to

Pageof 43
Sort By:
Expert Review of Hematology|February 17, 2011
Iron overload and allogeneic hematopoietic stem-cell transplantationJunya Kanda, Hiroshi Kawabata, Nelson J Chao
Current Oncology Reports|July 6, 2010
Haploidentical transplantation for leukemiaJunya Kanda, Nelson J Chao, David A Rizzieri
International Journal of Hematology|March 19, 2026
Evaluation of Real-world treatment patterns in Japanese patients with cGVHD: A retrospective claims database studyJunya Kanda, Kittima Wattanakamolkul, Hideyuki Muromine, et al.
International Journal of Hematology|March 4, 2011
Alemtuzumab for the prevention and treatment of graft-versus-host diseaseJunya Kanda, Richard D Lopez, David A Rizzieri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia]Junya Kanda, Kazuhisa Chonabayashi, Mitsumasa Watanabe, et al.
The Journal of Organic Chemistry|November 24, 2021
Synthesis of Bridged Indigos and Their Thermoisomerization and Photoisomerization BehaviorsJunya Kanda, Naoki Egami, Takahiro Sasamori, et al.
Haematologica|June 7, 2007
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's diseaseHiroshi Kawabata, Naohisa Tomosugi, Junya Kanda, et al.
International Journal of Hematology|November 17, 2009
Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell linesJunya Kanda, Tatsuki Uchiyama, Naohisa Tomosugi, et al.
BMJ Open|June 30, 2025
Protocol for a multicentre, open-label, dose-escalation phase I/II study evaluating the tolerability, safety, efficacy and pharmacokinetics of repeated continuous intravenous PPMX-T003 in patients with aggressive natural killer cell leukaemiaNoriko Fukuhara, Makoto Onizuka, Junya Kanda, et al.
International Cancer Conference Journal|July 5, 2021
Definitive radiotherapy for secondary esophageal cancer after allogeneic hematopoietic stem cell transplantationAki Ino, Katsuyuki Sakanaka, Hiroyuki Inoo, et al.
Pageof 43

Showing results (11-20 of 422) with videos related to

Sort By:
Pageof 43
Expert Review of Hematology|February 17, 2011
Iron overload and allogeneic hematopoietic stem-cell transplantationJunya Kanda, Hiroshi Kawabata, Nelson J Chao
Current Oncology Reports|July 6, 2010
Haploidentical transplantation for leukemiaJunya Kanda, Nelson J Chao, David A Rizzieri
International Journal of Hematology|March 19, 2026
Evaluation of Real-world treatment patterns in Japanese patients with cGVHD: A retrospective claims database studyJunya Kanda, Kittima Wattanakamolkul, Hideyuki Muromine, et al.
International Journal of Hematology|March 4, 2011
Alemtuzumab for the prevention and treatment of graft-versus-host diseaseJunya Kanda, Richard D Lopez, David A Rizzieri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia]Junya Kanda, Kazuhisa Chonabayashi, Mitsumasa Watanabe, et al.
The Journal of Organic Chemistry|November 24, 2021
Synthesis of Bridged Indigos and Their Thermoisomerization and Photoisomerization BehaviorsJunya Kanda, Naoki Egami, Takahiro Sasamori, et al.
Haematologica|June 7, 2007
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's diseaseHiroshi Kawabata, Naohisa Tomosugi, Junya Kanda, et al.
International Journal of Hematology|November 17, 2009
Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell linesJunya Kanda, Tatsuki Uchiyama, Naohisa Tomosugi, et al.
BMJ Open|June 30, 2025
Protocol for a multicentre, open-label, dose-escalation phase I/II study evaluating the tolerability, safety, efficacy and pharmacokinetics of repeated continuous intravenous PPMX-T003 in patients with aggressive natural killer cell leukaemiaNoriko Fukuhara, Makoto Onizuka, Junya Kanda, et al.
International Cancer Conference Journal|July 5, 2021
Definitive radiotherapy for secondary esophageal cancer after allogeneic hematopoietic stem cell transplantationAki Ino, Katsuyuki Sakanaka, Hiroyuki Inoo, et al.
Pageof 43